(INCY:Consolidated Issue Listed on NASDAQ Global Select )
Roy A. Whitfield
Co-Founder, Incyte Corporation
|Age||Total Calculated Compensation||This person is connected to 47 board members in 4 different organizations across 6 different industries.|
See Board Relationships
Mr. Roy A. Whitfield served as the Chief Executive Officer of Hexagen PLC. Mr. Whitfield has over 20 years of management and governance experience in the biotechnology industry. He co-founded Incyte Corp., (formerly, Incyte Genomics, Inc.) in 1991 and served as its Chairman of the Board from November 2001 to June 24, 2003, Chief Executive Officer from June 1993 to November 2001, President from June 1991 to January 1997 and Treasurer from April 1991 to October 1995. At ...
1801 Augustine Cut-OffPhone: 302-498-6700
Wilmington, Delaware 19803
Board Members Memberships*
Independent Director and Chairman of Nominating & Corporate Governance Committee
Director and chairman of Science and Business Advisory Board
Director, Member of Audit Committee and Member of Compensation Committee
Director, Member of Compensation Committee and Member of Audit Committee
University of Oxford
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Harvey J. Berger M.D.||Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee|
Ariad Pharmaceuticals Inc.
|Jean-Jacques Bienaime MBA||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|$771.2K||Compensation as of Fiscal Year 2014.|